Ganzhou Fifth People's Hospital Liver Interventional Department (Liver Tumor Center) was awarded the national minimally invasive tumor interventional construction center
Recently, the Center for Capacity Building and Continuing Education of the National Health and Health Commission announced the list of hospitals selected for the construction center of minimally invasive tumor intervention (in the direction of liver cancer and lung cancer), The Department of Hepatology Intervention (Liver Cancer Center) of Ganzhou Fifth People's Hospital has become the national center for minimally invasive tumor intervention (liver cancer direction), which indicates that the construction of hospital intervention technology and medical supporting facilities has been recognized at the national level.
The Interventional Department of Hepatology (Liver Cancer Center) of Ganzhou Fifth People's Hospital takes patients as the center and minimally invasive interventional diagnosis and treatment technology as the core, aiming at the whole life cycle diagnosis and treatment of liver cancer. Starting with the prevention, screening and accurate diagnosis of liver cancer, On the basis of strong internal medicine of liver diseases, Pay attention to the whole, combine surgery, minimally invasive intervention, integrated traditional Chinese and Western medicine, targeted, immunotherapy and other multidisciplinary, all-round and comprehensive treatment methods with the concept of peace, comfort, painlessness and nutrition, so as to benefit liver cancer patients in different periods. It has become a reality to turn "malignant diseases" into "chronic diseases", and more and more patients are getting a happy life with higher quality and longer survival time.
In recent years, with the development of disciplines, departments have explored a road suitable for their own development, devoted themselves to "minimally invasive, safe, economical and effective" minimally invasive treatment related to liver diseases, and become the liver tumor center of hospitals. The number of microwave/radiofrequency ablation (percutaneous) of liver malignant tumors ranks third in Jiangxi Province and first in Ganzhou City, and the number of liver malignant tumors plus transcatheter arterial chemoembolization ranks sixth in Jiangxi Province and third in Ganzhou City, with nearly 40 Tips operations every year.
The concept of diagnosis and treatment of liver diseases and liver tumors in departments is synchronized with that in Beishangguang. Joined the Southern Hospital of Southern Medical University-Greater Bay Area Liver Cancer Prevention Alliance of Ganzhou Fifth Hospital, He has joined Jiangxi Interventional Medicine Innovation Alliance, China Bleeding Center Alliance, China Liver Cancer Prevention Alliance and Southern Tumor Minimally Invasive Intervention Alliance, and established "Liver Tumor Minimally Invasive Intervention Joint Treatment Team" with Professor Huang Jinhua of Cancer Prevention Center of Sun Yat-sen University. Carried out liver tumor chemotherapy, Immunotherapy, Targeted drug therapy, Imaging interventional therapy ( TACE) C-arm guided hepatic arterial infusion chemotherapy including liver cancer ( HAIC), partial splenic artery embolization (PSE), percutaneous biliary catheterization (PTCD), percutaneous transhepatic gastric coronary vein embolization (PTVE), transjugular intrahepatic portosystemic shunt (TIPS), hepatic hemangioma sclerosis, color Doppler ultrasound or CT guidance including radio frequency, microwave, absolute alcohol ablation, hepatic cyst/abscess drainage, various percutaneous biopsy, etc. It can treat primary liver cancer, hypersplenism due to liver cirrhosis, benign and malignant obstruction of biliary tract, repeated upper gastrointestinal bleeding or intractable ascites caused by portal hypertension due to liver cirrhosis, hepatic hemangioma, hepatic cyst abscess, etc., so as to maximize the treatment effect, prolong the survival time and benefit the patients.
